The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Anxiety disorders in patients with Parkinson's disease
Abstract
To study the prevalence and importance of anxiety disorders in patients with idiopathic Parkinson's disease, the authors systematically evaluated 24 parkinsonian patients for the presence of DSM-III-R axis I syndromes. Nine subjects (38%) had a clinically significant current anxiety disorder. Severity of anxiety was not correlated with severity of parkinsonian symptoms, cumulative duration of L-dopa exposure, or current dose of L-dopa. These findings suggest that anxiety disorders should be considered in the medical evaluation and treatment of parkinsonian patients and that further attention should be paid to the role of the dopaminergic system in anxiety and phobic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
A Rating Instrument For Anxiety Disorders
Zung, W. W. K. (1971) · Psychosomatics · doi:10.1016/s0033-3182(71)71479-0 · Cited by 4,578
Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites
Robins, L. N. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790210031005 · Cited by 2,550
Six-Month Prevalence of Psychiatric Disorders in Three Communities: 1980 to 1982
Myers, J. K. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790210041006 · Cited by 1,581
"ON-OFF" EFFECTS IN PATIENTS WITH PARKINSON'S DISEASE ON CHRONIC LEVODOPA THERAPY
Marsden, C. D., & Parkes, J. D. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91416-1 · Cited by 661
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.8.976 · Cited by 641
Depression in Parkinson's disease: a quantitative and qualitative analysis.
Gotham, A. M., Brown, R. G., & Marsden, C. D. (1986) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.49.4.381 · Cited by 388
Mood Disorder and Multiple Sclerosis
Joffe, R. T., Lippert, G. P., Gray, T. A., Sawa, G., & Horvath, Z. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520160018007 · Cited by 387
Von Korff, M. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800140058008 · Cited by 355
Popkin, M. K. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800250078010 · Cited by 217
Depression in Patients with Parkinsonism
Robins, A. H. (1976) · British Journal of Psychiatry · doi:10.1192/bjp.128.2.141 · Cited by 185
Psychiatric Side Effects of Levodopa in Man
Goodwin, F. K. (1971) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1971.03190260031009 · Cited by 164
Some Biochemical Correlates of Panic Attacks with Agoraphobia and Their Response to a New Treatment
SHEEHAN, D. V., COLEMAN, J. H., GREENBLATT, D. J., JONES, K. J., LEVINE, P. H., ORSULAK, P. J., PETERSON, M., SCHILDKRAUT, J. J., UZOGARA, E., & WATKINS, D. (1984) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198404020-00002 · Cited by 159
Somatization and depression in fibromyalgia syndrome
Kirmayer, L. J., Robbins, J. M., & Kapusta, M. A. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.8.950 · Cited by 156
Four Types of Social Phobia in a Community Sample
Pollard, C. A., & Henderson, J. G. (1988) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198807000-00006 · Cited by 149
Evidence for atypical depression in Parkinson's disease
Schiffer, R. B., Kurlan, R., Rubin, A., & Boer, S. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.8.1020 · Cited by 127
Mindham, R. H. S., MARSDEN, C. D., & Parkes, J. D. (1976) · Psychological Medicine · doi:10.1017/s0033291700007467 · Cited by 87
CSF dopamine levels correlate with extraversion in depressed patients
King, R., Mefford, I. N., Wang, C., Murchison, A., Caligari, E. J., & Berger, P. A. (1986) · Psychiatry Research · doi:10.1016/0165-1781(86)90123-x · Cited by 72
Plasma HVA and anxiety in patients with panic disorder
Roy‐Byrne, P., Uhde, T. W., Sack, D. A., Linnoila, M., & Post, R. M. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90253-2 · Cited by 53
MAOIs: Impact on social behavior
Liebowitz, M. R., Campeas, R. B., & Hollander, E. (1987) · Psychiatry Research · doi:10.1016/0165-1781(87)90054-0 · Cited by 40
Parkinson's Disease Complicated by Anxiety
Routh, L. C., Black, J. L., & Ahlskog, J. E. (1987) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65226-4 · Cited by 27
Treatment of Parkinsonʼs disease with dopamine agonists: A review
LIEBERMAN, A. N., Neophytides, A. N., Kupersmith, M. J., Casson, I. R., Durso, R., Foo, S. H., Khayali, M., Tartaro, T., & Goldstein, M. (1979) · The American Journal of the Medical Sciences · doi:10.1097/00000441-197907000-00008 · Cited by 15
Cited by
Stein, M. B., & Stein, D. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60488-2 · Cited by 1,137
Self-citationThe scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow, C. W., Stern, M. B., & Sethi, K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a1d44c · Cited by 908
Anxiety disorders in older adults: a comprehensive review
Wolitzky-Taylor, K. B., Castriotta, N., Lenze, E. J., Stanley, M. A., & Craske, M. G. (2010) · Depression and Anxiety · doi:10.1002/da.20653 · Cited by 726
An algorithm (decision tree) for the management of Parkinson’s disease (2001): Treatment Guidelines
Olanow, C. W., Watts, R. L., & Koller, W. C. (2001) · Neurology · doi:10.1212/wnl.56.suppl_5.s1 · Cited by 715
Neuropsychiatric symptoms in Parkinson's disease
Aarsland, D., Marsh, L., & Schrag, A. (2009) · Movement Disorders · doi:10.1002/mds.22589 · Cited by 557
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1990-02-01
- Volume
- 147
- Issue
- 2
- Pages
- 217-220
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W1721898348
- Cited by
- 285
- References
- 24
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.